Stock 4002 MOUWASAT MEDICAL SERVICES COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Financials Mouwasat Medical Services Company

Equities

4002

SA12C051UH11

Healthcare Facilities & Services

End-of-day quote Saudi Arabian S.E.
Other stock markets
 06:00:00 2024-04-27 pm EDT 		5-day change 1st Jan Change
132.4 SAR -1.93% Intraday chart for Mouwasat Medical Services Company -2.93% +18.43%
Mar. 28 Mouwasat Medical Services Company Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 25 Saudi Arabia's Mouwasat Medical Services Reports Improved FY23 Profit, Revenue MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 8,800 13,800 17,380 20,900 22,360 27,000 - -
Enterprise Value (EV) 1 9,266 14,340 17,952 21,537 22,999 27,531 27,340 27,144
P/E ratio 20.9 x 26.1 x 30.1 x 34.9 x 34 x 33.2 x 28.9 x 24.8 x
Yield 1.99% 1.81% 1.58% 1.44% 1.57% 1.87% 2.12% 2.37%
Capitalization / Revenue 4.74 x 6.75 x 8.11 x 8.95 x 8.26 x 8.61 x 7.53 x 6.47 x
EV / Revenue 4.99 x 7.01 x 8.37 x 9.23 x 8.5 x 8.78 x 7.63 x 6.51 x
EV / EBITDA 15.2 x 19.7 x 23 x 24 x 23.5 x 22.9 x 20.3 x 17.3 x
EV / FCF 24.6 x 57.5 x 50.1 x 52.6 x 43.6 x 54.2 x 33.6 x 24.9 x
FCF Yield 4.07% 1.74% 1.99% 1.9% 2.29% 1.84% 2.98% 4.01%
Price to Book 4.5 x 6.05 x 6.67 x 7.15 x 6.82 x 7.21 x 6.82 x 5.73 x
Nbr of stocks (in thousands) 200,000 200,000 200,000 200,000 200,000 200,000 - -
Reference price 2 44.00 69.00 86.90 104.5 111.8 132.4 132.4 132.4
Announcement Date 3/8/20 3/15/21 3/16/22 3/28/23 3/24/24 - - -
1SAR in Million2SAR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,857 2,045 2,144 2,334 2,706 3,135 3,585 4,172
EBITDA 1 608.7 726.2 779.4 897.6 980.3 1,204 1,345 1,569
EBIT 1 470.5 577.8 621.9 663.1 756.9 915.2 1,041 1,225
Operating Margin 25.33% 28.26% 29.01% 28.41% 27.97% 29.19% 29.04% 29.37%
Earnings before Tax (EBT) 1 434.5 543.4 632.2 660.3 727.1 888.2 987.4 1,160
Net income 1 421 528.2 578.2 599.3 657.7 841.3 926.7 1,105
Net margin 22.67% 25.83% 26.96% 25.68% 24.31% 26.84% 25.85% 26.49%
EPS 2 2.105 2.640 2.890 2.995 3.290 3.987 4.576 5.344
Free Cash Flow 1 376.7 249.6 358.1 409.1 527.2 507.5 814.5 1,088
FCF margin 20.28% 12.2% 16.7% 17.53% 19.49% 16.19% 22.72% 26.09%
FCF Conversion (EBITDA) 61.89% 34.37% 45.94% 45.58% 53.78% 42.14% 60.58% 69.39%
FCF Conversion (Net income) 89.48% 47.25% 61.94% 68.27% 80.17% 60.32% 87.89% 98.5%
Dividend per Share 2 0.8750 1.250 1.375 1.500 1.750 2.475 2.804 3.143
Announcement Date 3/8/20 3/15/21 3/16/22 3/28/23 3/24/24 - - -
1SAR in Million2SAR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 531 537.4 567 557.9 549.1 660.1 664.2 627.3 640.9 773.1 759.2 696.7 711.9 858.2
EBITDA - - 200.8 - - 308.9 - - - - - - - -
EBIT 1 150.1 143 159.7 155.3 139.3 208.8 192.6 171.6 182.3 210.4 238 222.8 227.7 246.5
Operating Margin 28.27% 26.61% 28.16% 27.85% 25.36% 31.63% 29% 27.35% 28.44% 27.21% 31.35% 31.99% 31.99% 28.72%
Earnings before Tax (EBT) - - - - - - - - - - - - - -
Net income 1 142.7 133.1 150.2 141.5 122.2 185.4 166.6 150.5 156.4 184.2 209.2 - - -
Net margin 26.87% 24.76% 26.49% 25.36% 22.25% 28.09% 25.08% 24% 24.4% 23.82% 27.55% - - -
EPS 2 - - - - 0.6100 0.9250 0.8350 1.510 0.7800 0.9200 1.040 - - -
Dividend per Share - - - - - - - - - - - - - -
Announcement Date 10/31/21 3/16/22 5/15/22 8/11/22 11/3/22 3/28/23 5/11/23 8/7/23 11/6/23 3/24/24 - - - -
1SAR in Million2SAR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 466 540 572 637 639 531 340 144
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 0.7649 x 0.7439 x 0.7339 x 0.71 x 0.6523 x 0.4406 x 0.2531 x 0.0919 x
Free Cash Flow 1 377 250 358 409 527 508 814 1,088
ROE (net income / shareholders' equity) 23% 24.9% 23.7% 21.7% 21.2% 22% 23.7% 25%
ROA (Net income/ Total Assets) 12.8% 15.1% 15% 13.7% 13.7% 14.6% 14.6% 15.8%
Assets 1 3,288 3,489 3,854 4,360 4,813 5,777 6,365 6,979
Book Value Per Share 2 9.780 22.80 13.00 14.60 16.40 18.40 19.40 23.10
Cash Flow per Share 2 3.210 4.830 3.410 3.540 4.070 4.710 5.530 6.170
Capex 1 265 234 327 298 287 398 262 176
Capex / Sales 14.27% 11.43% 15.25% 12.78% 10.59% 12.7% 7.3% 4.21%
Announcement Date 3/8/20 3/15/21 3/16/22 3/28/23 3/24/24 - - -
1SAR in Million2SAR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Mouwasat Medical Services Company

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
132.4 SAR
Average target price
126.3 SAR
Spread / Average Target
-4.61%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Hospitals, Clinics & Primary Care Services

1st Jan change Capi.
MOUWASAT MEDICAL SERVICES COMPANY Stock Mouwasat Medical Services Company
+18.43% 7.2B
AIER EYE HOSPITAL GROUP CO., LTD. Stock Aier Eye Hospital Group Co., Ltd.
-20.16% 16.21B
BANGKOK DUSIT MEDICAL SERVICES Stock Bangkok Dusit Medical Services
+4.50% 12.44B
IHH HEALTHCARE Stock IHH Healthcare
+3.98% 11.58B
APOLLO HOSPITALS ENTERPRISE LIMITED Stock Apollo Hospitals Enterprise Limited
+9.72% 10.79B
RAMSAY HEALTH CARE LIMITED Stock Ramsay Health Care Limited
-2.19% 7.68B
THE ENSIGN GROUP, INC. Stock The Ensign Group, Inc.
+4.49% 6.67B
GLOBAL HEALTH LIMITED Stock Global Health Limited
+50.89% 4.66B
DALLAH HEALTHCARE COMPANY Stock Dallah Healthcare Company
-5.12% 4.25B
BURJEEL HOLDINGS PLC Stock Burjeel Holdings PLC
-4.50% 4.21B
Hospitals, Clinics & Primary Care Services
  1. Stock Market
  2. Equities
  3. 4002 Stock
  4. Financials Mouwasat Medical Services Company